Penn Davis McFarland’s Precigen PGEN Stock Holding History

Penn Davis McFarland’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,273	Closed	-$258K	–	39
2016 Q3	$258K	Buy	+9,273	New	+$245K	0.07%	36

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Penn Davis McFarland's PGEN Position: Q4 2016 in Review

Penn Davis McFarland sold out of Precigen (PGEN) in Q4 2016, closing a stake of 9,273 shares — an estimated $258K sold.

Penn Davis McFarland first reported a position in PGEN in Q3 2016 and held it in 1 quarter. The position peaked at $258K in Q3 2016. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

Penn Davis McFarland reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
Penn Davis McFarland sold 9,273 Precigen shares in Q4 2016, an estimated $258K.
Penn Davis McFarland first reported a position in Precigen in Q3 2016 and held it in 1 quarter.
Penn Davis McFarland's Precigen position peaked at $258K in Q3 2016.
171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Penn Davis McFarland's 13F filing for Q4 2016, filed 24 Jan 2017.